These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26242784)

  • 1. Moving Forward towards Standardized Analytical Methods for Extractables and Leachables Profiling Studies.
    Jenke D
    PDA J Pharm Sci Technol; 2015; 69(4):471-6. PubMed ID: 26242784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.
    Jenke D; Carlson T
    PDA J Pharm Sci Technol; 2014; 68(5):407-55. PubMed ID: 25336416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
    Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
    PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best practices for extractables and leachables in orally inhaled and nasal drug products: an overview of the PQRI recommendations.
    Norwood DL; Paskiet D; Ruberto M; Feinberg T; Schroeder A; Poochikian G; Wang Q; Deng TJ; DeGrazio F; Munos MK; Nagao LM
    Pharm Res; 2008 Apr; 25(4):727-39. PubMed ID: 18183477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 1-Introduction to Errors in Chromatographic Screening for Organic Extractables and Leachables and Discussion of the Errors of Omission.
    Christiaens P; Beusen JM; Verlinde P; Baeten J; Jenke D
    PDA J Pharm Sci Technol; 2020; 74(1):90-107. PubMed ID: 31209164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on the PQRI Extractables and Leachables "Safety Thresholds and Best Practices" Recommendations for Inhalation Drug Products.
    Norwood DL; Nagao LM; Stults CL
    PDA J Pharm Sci Technol; 2013; 67(5):413-29. PubMed ID: 24084658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Top ten hot topics in parenteral science and technology.
    Akers MJ; Nail SL; Saffell-Clemmer W
    PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP).
    Paskiet D; Jenke D; Ball D; Houston C; Norwood DL; Markovic I
    PDA J Pharm Sci Technol; 2013; 67(5):430-47. PubMed ID: 24084659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extractables and leachables considerations for prefilled syringes.
    Jenke DR
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1591-600. PubMed ID: 24955780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the chemical compatibility of plastic contact materials and pharmaceutical products; safety considerations related to extractables and leachables.
    Jenke D
    J Pharm Sci; 2007 Oct; 96(10):2566-81. PubMed ID: 17701994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extractables Screening of Polypropylene Resins Used in Pharmaceutical Packaging for Safety Hazards.
    Jenke D
    PDA J Pharm Sci Technol; 2017; 71(5):346-367. PubMed ID: 28512176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extractables characterization for five materials of construction representative of packaging systems used for parenteral and ophthalmic drug products.
    Jenke D; Castner J; Egert T; Feinberg T; Hendricker A; Houston C; Hunt DG; Lynch M; Shaw A; Nicholas K; Norwood DL; Paskiet D; Ruberto M; Smith EJ; Holcomb F
    PDA J Pharm Sci Technol; 2013; 67(5):448-511. PubMed ID: 24084660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correcting the Analytical Evaluation Threshold (AET) and Reported Extractable's Concentrations for Analytical Response Factor Uncertainty Associated with Chromatographic Screening for Extractables/Leachables.
    Jenke D
    PDA J Pharm Sci Technol; 2020; 74(3):348-358. PubMed ID: 32295860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking extractables and leachables in container/closure applications.
    Jenke DR
    PDA J Pharm Sci Technol; 2005; 59(4):265-81. PubMed ID: 16218205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and quantification of extractables and leachables in laminated film and pouches for pharmaceutical packaging.
    Fu C; Zhang X; Lei S; Zou M; Wang L; Jiao J; Yang Q
    J Pharm Biomed Anal; 2022 Oct; 220():115015. PubMed ID: 36054946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 2-Errors of Inexact Identification and Inaccurate Quantitation.
    Christiaens P; Beusen JM; Verlinde P; Baeten J; Jenke D
    PDA J Pharm Sci Technol; 2020; 74(1):108-133. PubMed ID: 31308065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Analysis of the Effect of Extraction Solvents on the Chemical Composition of Extraction Solutions and the Analytical Implications in Extractables and Leachables Studies.
    Li J; Sobańtka A
    J Pharm Biomed Anal; 2023 Jan; 222():115081. PubMed ID: 36244085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a reference standard database for use in the qualitative and semi-quantitative analysis of pharmaceutical contact materials within an extractables survey by GC-MS.
    Zdravkovic SA; Duong CT; Hellenbrand AA; Duff SR; Dreger AL
    J Pharm Biomed Anal; 2018 Mar; 151():49-60. PubMed ID: 29306734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of thermal desorption GC-MS to characterize packaging materials for potential extractables.
    Zweiben C; Shaw AJ
    PDA J Pharm Sci Technol; 2009; 63(4):353-9. PubMed ID: 20088248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing relative response factor variation using a multidetector approach for extractables and leachables (E&L) analysis to mitigate the need for uncertainty factors.
    Jordi MA; Rowland K; Liu W; Cao X; Zong J; Ren Y; Liang Z; Zhou X; Louis M; Lerner K
    J Pharm Biomed Anal; 2020 Jul; 186():113334. PubMed ID: 32387747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.